Lophos Holdings, Inc. (TSE:MESC) has released an update.
Lophos Holdings Inc. concluded its annual general meeting with the election of four directors and the approval of a stock option plan, while also granting 3.26 million stock options with immediate vesting. The company’s subsidiary, Lophos Pharmaceuticals Corp., continues to excel in the biosciences sector, focusing on peyote research and sales under a special license.
For further insights into TSE:MESC stock, check out TipRanks’ Stock Analysis page.
